Loading…

PB1998: WEEKLY OPPOSED TO BI‐WEEKLY BORTEZOMIB AS PART OF INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA IS BETTER TOLERATED AND EQUALLY EFFICIENT: REAL‐WORLD DATA FROM A RETROSPECTIVE AUDIT

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6 (Suppl), p.1869-1870
Main Authors:	Faulkner, L., Garg, M., Suresh, C.
Format:	Article
Language:	English
Subjects:	Publication Only
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!